Inhibition of the Rho/ROCK pathway enhances the efficacy of cisplatin through the blockage of hypoxia-inducible factor-1α in human ovarian cancer cells

Tsuyoshi Ohta(Yamagata University), Hirohisa Kurachi(Osaka Women's and Children's Hospital), Toshifumi Takahashi(Fukushima Medical University), Kazuhiro Takahashi, Mitsuyoshi Amita(Institute of Animal Sciences), Noriko Henmi(Yamagata University), Tae Shibuya(Yamagata University)
Cancer Biology & Therapy
January 1, 2012
10.4161/cbt.13.1.18440
Cited by 55

Related Papers

Estrogen Induces the Akt-dependent Activation of Endothelial Nitric-oxide Synthase in Vascular Endothelial Cells
|Journal of Biological Chemistry|2001|387
Complete and unidirectional conversion of human embryonic stem cells to trophoblast by BMP4
|Proceedings of the National Academy of Sciences|2013|280
Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
|PubMed|2000|249
Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells
|Molecular Cancer Research|2016|232
A Physiological Role of Epidermal Growth Factor in Male Reproductive Function
|Science|1986|222